Meridian Biosciences

The device, available for license from the Lawrence Livermore National Laboratories Industrial Partnerships Office, integrates a single-tube nucleic acid extraction method with loop-mediated isothermal amplification or reverse transcriptase LAMP.

Asuragen, Life Tech launch BCR/ABL1 Quant test in Europe; Palex Medical to distribute Molecular Detection’s MRSA assay in Spain; Meridian Biosciences gets FDA nod for C. difficile molecular amplification assay.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.